Applications Published 14 March 2001

Published: 20-Dec-2001

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).

  • Use of micro-organism extracts in cosmetic or pharmaceutical compsns
    Pierre Fabre Dermo-Cosmetics 1082091*

  • Anti-germ attachment compsn
    Colgate-Palmolive Company 1082092*

  • Skin cleansing compsn providing enhanced perfumed deposition
    Colgate-Palmolive Company 1082094*

  • N-oxide of heterocyclic ester, amide, thioester or ketone hair growth compsns and uses
    GPI NIL Holdings 1082095*

  • Skin treatment compsns and the use thereof
    Natural ASA 1082096*

  • Use of sophorolipids comprising diacetyl lactones as agent for stimulating skin fibroblast metabolism
    Institut Francais du Petrole; Sophor 1082097*

  • Cosmetic treatment method for fighting against skin ageing effects
    Guerlain 1082098*

  • Cosmetic or dermatologic preparations containing catechins or green tea extract
    Beiersdorf 1082100*

  • Biologicall active compsn
    Bioglan 1082102*

  • Spill resistant pharmaceutical compsns
    Taro Pharmaceutical 1082103*

  • Novel poly(methylidene malonate) microspheres, preparation method and pharmaceutical compsns containing them
    Virsol 1082104*

  • Controlled drug delivery system using the conjugation of drug to biodegradable polyester
    Mogam Biotechnology Research Institute 1082105*

  • Sublingual buccal effervescent
    Cima Labs 1082106*

  • Controlled release lipoic acid
    Medical Research Institute 1082107*

  • Improvements in medicaments for asthma treatment
    Britannia Pharmaceuticals 1082108*

  • Oral formulation comprising biguanide and an organic acid
    Sumitomo Pharmaceuticals 1082109*

  • Use of compounds for the elevation of pyruvate dehydrogenase activity
    AstraZeneca 1082110*

  • Assay for identification of compounds that promote melanin production and retinoid-like compounds identified by said assay
    Galderma Research and Development 1082111*

  • Endogenous nitric oxide synthesis under conditions of low oxygen tension
    Nitromed 1082112*

  • Compsns and methods for alleiviating impaired memory function, memory loss and reducing recovery time in anaesthetised mammals
    Carlen, Peter Louis 1082113*

  • Hydroxyomeprazole compsns and uses
    Sepracor 1082114*

  • Heterocyclic cis cyclopropane derivatives as melatonergic agents
    Bristol-Myers Squibb 1082115*

  • Use of 4-piperidinemethanol derivatives in the treatment of neurodevelopmental disorders
    A Carlsson Research 1082116*

  • A stabilised antihistamine syrup containing aminopolycarboxylic acid as stabiliser
    Schering Corp 1082117*

  • Mehod for the normalisation of sexual response and amelioration of long-term genital tissue degradation
    Queen's University at Kingston 1082118*

  • Microemulsion preconcentrates containing a piperidine substance P antagonist
    Novartis 1082119*

  • Pyrrolo[2,3D]pyrimidine compsns and their uses
    OSI Pharmaceuticals 1082120*

  • HIV integrase inhibitors
    Merck; Tularik 1082121*

  • Isolflavonoids for treatment and prevention of migraine headaches
    Gorbach, Sherwood L 1082122*

  • Use of a nucleic acid-binding chemotherapeutic agent, and a pharmaceutical compsn
    Faculteit Geneeskunde Universiteit Utrecht 1082123*

  • Pharmaceutical or cosmetic compsn and method for cosmetic treatment of angiogenic disorders
    Pierre Fabre Dermo-Cosmetique 1082125*

  • Novel peptides
    Hadasit Medical Research Services and Development 1082126*

  • Succinimide inhibitors of interleukin-1g(B) converting enzyme
    Warner-Lambert; BASF 1082127*

  • Lysine containing peptides for treatment of heart disease.
    Deghenghi, Romano 1082128*

  • Method for the treatment of fertility disorders
    Asta Medica 1082129*

  • Use of cyclosporins in the treatment of inflammatory autoimmune diseases
    Novartis 1082130*

  • Immunoregulator
    Erasmus University Rotterdam 1082131*

  • Recombinant human interferon beta-1A (IFN-beta-1A) formulation
    Biogen 1082132*

  • Pharmaceutical formulations for IGF/IGFBP
    Celtrix Pharmaceuticals 1082133*

  • Compsn comrpising tumour cells and extracts and method of using thereof
    Thomas Jefferson University 1082134*

  • Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants
    Chiron Corp 1082135*

  • The cytokine family member, 2-19
    SmithKline Beecham 1082136*

  • Reversal of proinflammatory response by ligating the macrophage FCg(G)RI receptor
    Temple University of the Commonealth System of Higher Education 1082137*

  • Texaphin conjugates and uses thereof
    Board of Regents of the University of Texas System; Pharmacyclics 1082138*

  • Carrier for in vivo delivery of a therapeutic agent
    University of Medicine and Dentistry of New Jersey 1082139*

  • Gene expression method
    University of Pittsburgh of the Commonwealth System of Higher Education 1082140*

  • CD40 binding molecules and CTL peptides for treating tumours
    Leiden University Medical Centre 1082141*

  • Compsns and methods for delivery of genetic material, for altering neuronal growth, regeneration, and survival
    Selective Genetics 1082142*

  • MR signal-emitting coatings
    Wisconsin Alumni Research Foundation 1082143*

  • Slow release of fragrant compounds in perfumery using 2-benzoyl benzoates, 2-alkanoyl benzoates or alpha-keto esters
    Firmenich 1082287*

  • Process for preparing paraphenylenediamine derivatives
    Uniroyal Chemical 1082288*

  • Methods for identifying novel multimeric agents that modulate receptors
    Advanced Medicine 1082289*

  • Process for the preparation of aceclofenac
    Russinsky 1082290*

  • Chemical process for the stereoselective synthesis of R-(-)-carnitine
    Sigma-Tau Industrie Farmaceutiche Riunite 1082291*

  • Control of pain with endogenous cannabinoids
    Neurosciences Research Foundation 1082292*

  • Formoterol polymorphs
    Sepracor 1082293*

  • Phenylalanine derivatives as integrin inhibitors
    Celltech Therapeutics 1082294*

  • Substituted 4-biarylbutyric and biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
    Bayer 1082295*

  • Stabilisation of organic polyisocyanates
    Bayer 1082296*

  • Substituted dithio-bis-nitrobenzenes and their applications
    Institut Pasteur de Lille; Centre National de la Recherche Scientifique 1082297*

  • !g(A)-hydroxy-25-ene-vitamin D, analogues and uses thereof
    Bone Care International 1082298*

  • C11 oxymyl and hydroxylamino prostaglandins useful as medicaments
    Procter & Gamble 1082299*

  • 3-[(1'-N-methylamino)ethyl-N-benzyl]pyrrolidine monomethanesulfonate
    Pharmacia & Upjohn 1082300*

  • Ureas and carbamates of N-heterocyclic carboxylic acids and carboxylic acid isoesters
    GPI NIL 1082301*

  • A VLA-4 inhibitor: Omepupa-V
    Biogen 1082302*

  • Heterocyclic derivatives which inhibit factor XA
    AstraZeneca 1082303*

  • New crystalline polymorphic form of 1-methyl-5-P-toluoylpyrrole-2-acetamidoacetic acid guaiacyl ester (med 15)
    Sigma-Tau Industrie Farmaceutische Riunite 1082304*

  • Pyrrole substituted 2-indolinone protein kinase inhibitors
    Sugen 1082305*

  • Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
    Warner-Lambert 1082306*

  • Processes and intermediates for preparing 2-substituted piperidine stereoisomers
    Celgene Corp 1082307*

  • Heterocyclically substituted amides used as calpain inhibitors
    BASF 1082308*

  • Process for the preparation of a 3(2H)-pyridazinone-4-substituted amin0-5-chloro-derivative
    Egis Gyogyszergyar 1082309*

  • Methods of identifying and using HLA binding compounds as HLA-agonists and antagonists
    Georgetown University 1082310*

  • Quinazolines for treating brain tumours
    Parker Hughes Institute 1082311*

  • Sulfonyl amino (thio)carbonyl triazoline (thi)ons having alkenyl substituents
    Bayer 1082312*

  • Bicyclic compounds, process for their preparation and pharmaceutical compsns containing them
    Dr Reddy's Research Foundation 1082313*

  • New dipeptidyl peptidase IV effectors
    Probiodrug Gesellschsft fuer Arzneimittelforschung 1082314*

  • Potassium channel inhibitors
    Icagen; Eli Lilly 1082315*

  • Methods and useful intermediates for paclitaxel synthesis from C-7, C-10 di-CBZ baccatin III
    Napro Biotherapeutics 1082316*

  • Method for producing phthalic anhydride by means of catalytic vapour phase oxidation of oxylol/naphthalene mixtures
    BASF 1082317*

  • Thiacrown ether compound
    BetzDearborn 1082318*

  • Benzocarbazol and indenoinole derived estrogenic agents.
    American Home Products 1082319*

  • Novel substituted imidazole compounds
    SmithKline Beecham 1082320*

  • Heterocyclic derivatives which inhibit factor XA
    AstraZeneca 1082321*

  • Oxazolidinone derivatives, process for their preparation and pharmaceutical compsns containing them
    AstraZeneca 1082322*

  • Oxazolidinone derivatives, process for preparing them and pharmaceutical compsns containing them
    AstraZeneca 1082323*

  • Imidazopyridine thrombin inhibitors
    Merck 1082324*

  • Naphthosulphamylmethyl penem antibacterials
    Merck 1082325*

  • Cephalosporins having cyclic aminoguanidine substituents as antibiotics
    Biochemie 1082326*

  • Perfluorinated organo substituted cylcosiloxanes and copolymers prepared from these cyclosiloxanes
    Archimica (Florida) 1082327*

  • Production of optically active phospholanes
    BASF 1082328*

  • Platinum complex, its preparation and therapeutic application
    Pliva-Lachema 1082329*

  • Platinum complex, its preparation and therapeutic application
    Pliva-Lachema 1082330*

  • Platinum complex conjugated to cyclotriphosphazene, its preparation, and anticancer agent comprising the same
    Korea Institute of Science and Technology; Il-Yang Pharm 1082331*

  • Silica-guanidiniumthiocyanate DNA isolation doing casein
    Academische Ziekenhuis bij de Universiteit van Amsterdam 1082332*

  • Thiocolchicoside derivative, preparation and therapeutic application
    Sanofi-Synthelabo 1082333*

  • ALG-2LP, ALG-2-like molecules and uses therefore
    Millennium Pharmaceuticals 1082334*

  • Novel secreted and membrane-associated proteins and uses therefore
    Millennium Pharmaceuticals 1082335*

  • Apoptosis modulators that interact with the Huntington's disease gene
    University of British Columbia 1082336*

  • 17 beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
    Research Triangle Institute 1082337*

  • 17-beta-nitro-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
    Research Triangle Institute 1082338*

  • Rationally designed peptides, production and use thereof
    Affina Immuntechnik 1082339*

  • Peptide vaccine for canine allergy
    Idexx Laboratories 1082340*

  • Tumour antigen useful in diagnosis and therapy of prostate and colon cancer Urogenesys; Mitchell, Stephen
    Chappell 1082341*

  • Vaccine for Pseudomonas aeruginosa
    The Governers of the University of Alberta 1082342*

  • Toxoplasma gondii antigens, P35, and uses thereof
    Aboot Laboratories 1082343*

  • Glycoproteins having lipid mobilising properties and cations thereof
    Tisdale, Michael John 1082344*

  • Method of designing agonists and antagonists to EGF receptor family
    Biomolecular Research Institute 1082345*

  • Specific binding proteins for treating canine allergy
    Idexx Laboratories 1082346*
    See more

    • You may also like

    Medical Devices

    Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

    Read more
    A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies

    Trending Articles

    1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
    2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
    3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
    4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
    5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

    Upcoming event

    Enhancing probiotic stability through smarter formulation and packaging strategies

    18 September 2025 | Virtual     See all

    You may also like

    Medical Devices

    Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

    A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
    Manufacturing

    Sapio Sciences introduces world’s first 3rd-generation ELN

    Sapio ELaiN is an AI-powered lab notebook designed to act as a scientific collaborator
    Manufacturing

    Signal Group launches MCERTS approved VOC emissions monitor

    New SOLAR CEMNEX analyser offers advanced compliance and connectivity features
    Research & Development

    Genoskin raises $8.7m in its first funding round to advance its ethical, human-based alternatives to animal testing

    The financing will drive Genoskin’s next phase of growth, with a view to scaling up operations in both the US and France
    You need to be a subscriber to read this article.
    Click here to find out more.
    Packaging

    Cloud labelling and serialisation: the new frontline of traceability in drug delivery

    As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence
    Manufacturing

    Sharp boosts autoinjector and pen assembly line capability with $20m investment in Pennsylvania facility

    The money will boost its autoinjector and pen assembly, labelling and packaging lines across various therapeutic areas at its facility in Macungie, meeting the rising demand for injectables
    Manufacturing

    L.B. Bohle to showcase machines for OSD, food and nutraceuticals at PACK EXPO 2025

    Company to present advanced blending, particle sizing and coating technologies at Las Vegas event
    Subscribe now